HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure Prophylaxis Trial

Benzer Materyaller

• CAPRISA 004 Tenofovir Microbicide Trial: No Impact of Tenofovir Gel on the HIV Transmission Bottleneck
  Yazar:: Valley-Omar, Ziyaad, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Sensitive Tenofovir Resistance Screening of HIV-1 From the Genital and Blood Compartments of Women With Breakthrough Infections in the CAPRISA 004 Tenofovir Gel Trial
  Yazar:: Wei, Xierong, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Preservation HIV-1-specific IFNγ+ CD4+ T cell responses in breakthrough infections following exposure to Tenofovir Gel in the CAPRISA 004 microbicide trial
  Yazar:: Mureithi, Marianne W., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
  Yazar:: Matthews, Lynn T., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
  Yazar:: Succop, Stacey M., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)